These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19740658)

  • 1. Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
    Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5893-7. PubMed ID: 19740658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: further insights into a class of triple re-uptake inhibitors.
    Micheli F; Cavanni P; Bettati M; Bonanomi G; Di Fabio R; Fazzolari E; Marchioro C; Roscic M; Tarsi L; Visentini F; Zonzini L; Worby A
    Bioorg Med Chem; 2011 Jun; 19(11):3451-61. PubMed ID: 21550808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
    Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.
    Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2329-32. PubMed ID: 19282174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake.
    Boot JR; Brace G; Delatour CL; Dezutter N; Fairhurst J; Findlay J; Gallagher PT; Hoes I; Mahadevan S; Mitchell SN; Rathmell RE; Richards SJ; Simmonds RG; Wallace L; Whatton MA
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5395-9. PubMed ID: 15454233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.
    Meltzer PC; Butler D; Deschamps JR; Madras BK
    J Med Chem; 2006 Feb; 49(4):1420-32. PubMed ID: 16480278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.
    Shao L; Ma J; Wang F; Malcolm SC; Hewitt MC; Campbell UC; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA
    Bioorg Med Chem Lett; 2011 Jan; 21(1):520-3. PubMed ID: 21095126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
    Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
    J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
    Wen H; Qin W; Yang G; Guo Y
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.
    Gong PK; Blough BE; Brieaddy LE; Huang X; Kuhar MJ; Navarro HA; Carroll FI
    J Med Chem; 2007 Jul; 50(15):3686-95. PubMed ID: 17602602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and inhibitory evaluation of 3-linked imipramines for the exploration of the S2 site of the human serotonin transporter.
    Brinkø A; Larsen MT; Koldsø H; Besenbacher L; Kolind A; Schiøtt B; Sinning S; Jensen HH
    Bioorg Med Chem; 2016 Jun; 24(12):2725-38. PubMed ID: 27160055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.
    Pechulis AD; Beck JP; Curry MA; Wolf MA; Harms AE; Xi N; Opalka C; Sweet MP; Yang Z; Vellekoop AS; Klos AM; Crocker PJ; Hassler C; Laws M; Kitchen DB; Smith MA; Olson RE; Liu S; Molino BF
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7219-22. PubMed ID: 23084899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antidepressant evaluation and docking studies of long-chain alkylnitroquipazines as serotonin transporter inhibitors.
    Gabrielsen M; Wołosewicz K; Zawadzka A; Kossakowski J; Nowak G; Wolak M; Stachowicz K; Siwek A; Ravna AW; Kufareva I; Kozerski L; Bednarek E; Sitkowski J; Bocian W; Abagyan R; Bojarski AJ; Sylte I; Chilmonczyk Z
    Chem Biol Drug Des; 2013 Jun; 81(6):695-706. PubMed ID: 23574807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.
    Greiner E; Boos TL; Prisinzano TE; De Martino MG; Zeglis B; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
    J Med Chem; 2006 Mar; 49(5):1766-72. PubMed ID: 16509591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants.
    Ryckmans T; Balançon L; Berton O; Genicot C; Lamberty Y; Lallemand B; Pasau P; Pirlot N; Quéré L; Talaga P
    Bioorg Med Chem Lett; 2002 Jan; 12(2):261-4. PubMed ID: 11755367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future directions for serotonin and antidepressants.
    Artigas F
    ACS Chem Neurosci; 2013 Jan; 4(1):5-8. PubMed ID: 23336036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.
    Voelker T; Xia H; Fandrick K; Johnson R; Janowsky A; Cashman JR
    Bioorg Med Chem; 2009 Mar; 17(5):2047-68. PubMed ID: 19201198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression.
    Degnan AP; Tora GO; Huang H; Conlon DA; Davis CD; Hanumegowda UM; Hou X; Hsiao Y; Hu J; Krause R; Li YW; Newton AE; Pieschl RL; Raybon J; Rosner T; Sun JH; Taber MT; Taylor SJ; Wong MK; Zhang H; Lodge NJ; Bronson JJ; Macor JE; Gillman KW
    ACS Chem Neurosci; 2016 Dec; 7(12):1635-1640. PubMed ID: 27744678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.
    Carroll FI; Blough BE; Abraham P; Mills AC; Holleman JA; Wolckenhauer SA; Decker AM; Landavazo A; McElroy KT; Navarro HA; Gatch MB; Forster MJ
    J Med Chem; 2009 Nov; 52(21):6768-81. PubMed ID: 19821577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
    Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
    PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.